Since 2020, whole genome sequencing (WGS) has been available as a frontline test in England for children with cancer, to enable a more comprehensive and precise diagnosis, and access to enhanced personalised treatments. However, challenges in implementing pathways to enable WGS, and a lack of education and training opportunities have been cited as the main factors for low uptake on this test across England.
East Genomics together with Wellcome Connecting Science and the University of Cambridge are inviting clinicians and pathologists from all UK paediatric oncology specialist centres, as well as cancer leads from the seven Genomics Laboratory Hubs in England to a one-day in-person workshop, for an open discussion. This initial event will provide an opportunity to share best practice, discuss the issues around implementation, and to collectively consider solutions to improve uptake across the UK.
The morning session, in which there are a number of key note speakers including Professor Dame Sue Hill, will be open to a wider audience via Zoom. To view the agenda and to register on the Wellcome Connecting Science webpage. A limited number of places are still available for key clinicians to attend the full day. To enquire about attending in-person please email email@example.com.
This workshop is a prelude to a planned series of educational multi-disciplinary team meetings (MDTs).
This is a Wellcome Connecting Science event developed in conjunction with NHS East Genomic Laboratory Hub, University of Cambridge Dept. of Paediatrics and the Wellcome Sanger Institute Cellular Genetics Programme, supported by Genomics England, Health Education England, CRUK Cambridge Centre Paediatric Cancer Programme, University of Cambridge, Cambridge University Hospitals NHS Foundation Trust and Cambridge Biomedical Research Centre.